Skip to Content

AHI 500 (Mycophenolate Mofetil 500 mg)

Pill with imprint AHI 500 is Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Accord Healthcare.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; autoimmune hepatitis; organ transplant, rejection prophylaxis; cogan's syndrome; bullous pemphigoid (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AHI 500

Mycophenolate mofetil 500 mg AHI 500
Mycophenolate mofetil 500 mg AHI 500
Mycophenolate mofetil 500 mg AHI 500 Front
Mycophenolate mofetil 500 mg AHI 500 Back

Mycophenolate Mofetil

AHI 500
500 mg
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Accord Healthcare
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.